Charles River Laboratories | CRL - SCHULD

Aktienkurs
159.51
Täglich Wechseln
1.51 0.96%
Monatlich
-4.80%
Jährlich
-1.14%
Q1 Prognose
148.99




SCHULD Veränderung Datum
Agilent USD 3.35B 55M 2025-09
Align Technology USD 121.27M 1.75M 2025-09
Bio-Rad Laboratories USD 1.4B 11.2M 2025-09
Bruker USD 2.01B 426.8M 2025-09
Cardinal Health USD 9.03B 505M 2025-09
Charles River Laboratories USD 2.63B 157.4M 2025-09
Cigna USD 34.04B 3.27B 2025-09
Concord Medical Services Hldg CNY 3.01B 27.15M 2023-06
CVS Health USD 64.57B 1.27B 2025-12
Danaher USD 18.42B 1.56B 2025-12
Dentsply International USD 2.48B 14M 2025-09
Elevance Health USD 32.05B 56M 2025-12
Galapagos EUR 7.5M 3.36M 2025-09
Hologic USD 2.63B 104.3M 2025-09
Humana USD 12.37B 238M 2025-12
Illumina USD 2.58B 22M 2025-09
Incyte USD 40.41M 855K 2025-12
Intrexon USD 0 13.82M 2024-06
IQVIA Holdings USD 15.72B 767M 2025-12
Laboratory Of America USD 6.53B 16.1M 2025-09
Lonza CHF 4.71B 915M 2024-12
McKesson USD 9.79B 141M 2025-09
Merck EUR 12.1B 2.7B 2025-09
Mettler Toledo International USD 2.21B 25.94M 2025-09
Novartis USD 32.64B 1.37B 2025-06
Pfizer USD 60.85B 78M 2025-09
Quest Diagnostics USD 6.38B 2M 2025-09
Revvity USD 3.37B 5.86M 2025-09
Thermo Fisher Scientific USD 35.68B 451M 2025-09
United Therapeutics USD 200M 100M 2025-03
UnitedHealth USD 78.39B 1.75B 2025-12
Veradigm USD 200.33M 431K 2022-09
Waters USD 1.49B 52.2M 2025-09
West Pharmaceutical Services USD 202.8M 100K 2025-12